Relations of Postload and Fasting Glucose With Incident Cardiovascular Disease and Mortality Late in Life: The Cardiovascular Health Study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 71, Issue 3, 2016, Pages 370-377

  Brutsaert, Erika F ^a   Shitole, Sanyog ^a   Biggs, Mary Lou ^b   Mukamal, Kenneth J ^c   DeBoer, Ian H ^b   Thacker, Evan L ^d   Barzilay, Joshua I ^e   Djoussé, Luc ^f   Ix, Joachim H ^g   Smith, Nicholas L ^b,h,j   Kaplan, Robert C ^a   Siscovick, David S ⁱ   Psaty, Bruce M ^b,j   Kizer, Jorge R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d BRIGHAM YOUNG UNIVERSITY   (United States)

^e KAISER PERMANENTE   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Seattle Epidemiologic Research and Information Center   (United States)

ⁱ NEW YORK ACADEMY OF MEDICINE   (United States)

^j CENTER FOR HEALTH STUDIES   (United States)

more..

Author keywords

Cardiovascular; Diabetes; Epidemiology; Risk factors

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

AGED; AGING; BLOOD; CARDIOVASCULAR DISEASES; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEALTH SURVEY; HUMAN; INCIDENCE; MALE; METABOLISM; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TRENDS; UNITED STATES;

AGED; AGING; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; GLUCOSE TOLERANCE TEST; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 84959911910     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glv106     Document Type: Article

References (30)

1. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37(suppl 1):S14-S80. doi:10.2337/dc14-S014.
2. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and prediabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2009;32:287-294. doi:10.2337/dc08-1296.
3. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe). Consequences of the new diagnostic criteria for diabetes in older men and women. Diabetes Care. 1999;22(10):1667-1671.
4. Decode Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161(3):397-405.
5. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 2002;25:1845-1850.
6. Di Angelantonio E, Gao P, Khan H, et al. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA. 2014;311(12):1225-1233. doi:10.1001/jama.2014.1873.
7. Barrett-Connor E, Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study. Diabetes Care. 1998;21:1236-1239.
8. Cederberg H, Saukkonen T, Laakso M, et al. Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study. Diabetes Care. 2010;33:2077-2083. doi:10.2337/dc10-0262.
9. Smith NL, Barzilay JI, Shaffer D, et al. Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med. 2002;162:209-216.
10. The Centers for Disease Control and Prevention. Trends in aging-United States and worldwide. MMWR Morb Mortal Wkly Rep. 2003;52(6):101-104, 106.
11. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-276.
12. Psaty BM, Kuller LH, Bild D, et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 1995;5:270-277.
13. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889-2934. doi:10.1016/jacc.2013.11.002.
14. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem. 1995;41:264-270.
15. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
16. Ives DG, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol. 1995;5:278-285.
17. Hastie T, Tibshirani R. Generalized additive models for medical research. Stat Methods Med Res. 1995;4:187-196.
18. Fine JP, Gray JR. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
19. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
20. Grønnesby JK, Borgan O. A method for checking regression models in survival analysis based on the risk score. Lifetime Data Anal. 1996;2:315-328.
21. Prevention. CDC. National Diabetes Statistics Report: Estimates of Diabetes and its Burden in the United States, 2014, Atlanta, GA: US. Department of Health and Human Services; 2014.
22. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care. 2006;29:2114-2116. doi:10.2337/dc06-1136.
23. Wahl PW, Savage PJ, Psaty BM, Orchard TJ, Robbins JA, Tracy RP. Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet. 1998;352:1012-1015. doi:10.1016/S0140-6736(98)04055-0.
24. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care. 2012;35:2650-2664. doi:10.2337/dc12-1801.
25. The Centers for Disease Control and Prevention. Prevalence of diabetes and impaired fasting glucose in adults-United States, 1999-2000. MMWR Morb Mortal Wkly Rep. 2003;52(35):833-837.
26. Vimalananda VG, Biggs ML, Rosenzweig JL, et al. The influence of sex on cardiovascular outcomes associated with diabetes among older black and white adults. J Diabetes Complications. 2014;28:316-322. doi:10.1016/j. jdiacomp.2013.12.004.
27. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol. 2004;159:882-890.
28. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003;290:486-494. doi:10.1001/jama.290.4.486.
29. Holman RR, Haffner SM, McMurray JJ, et al. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010;362(16):1463-1476. doi:10.1056/NEJMoa1001122.
30. Raz I, Ceriello A, Wilson PW, et al. Post hoc subgroup analysis of the HEART2D trial demonstrates lower cardiovascular risk in older patients targeting postprandial versus fasting/premeal glycemia. Diabetes Care. 2011;34:1511-1513. doi:10.2337/dc10-2375.